Search

Your search keyword '"Fellstrom, B."' showing total 120 results

Search Constraints

Start Over You searched for: Author "Fellstrom, B." Remove constraint Author: "Fellstrom, B."
120 results on '"Fellstrom, B."'

Search Results

1. Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy

2. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy

3. Attenuation of Torque teno viral load over time in kidney transplantation recipients treated with calcineurin inhibitors is mitigated after conversion to belatacept.

4. Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy

5. Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool

6. Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsy

7. Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update

8. Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy

9. Quantifying duration of proteinuria remission and association with clinical outcome in IgA nephropathy

13. Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction Tool

14. Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials

15. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: Evidence from the VALidation of IGA study cohort

16. Reproducibility of the Oxford classification of immunoglobulin A nephropathy, impact of biopsy scoring on treatment allocation and clinical relevance of disagreements: Evidence from the VALidation of IGA study cohort

17. Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathy

18. Tonsillectomy in a European Cohort of 1,147 Patients with IgA Nephropathy

19. Bardoxolone Methyl in Type 2 Diabetes and Stage 4 Chronic Kidney Disease

20. Evidence from the large VALIGA cohort validates the subclassification of focal segmental glomerulosclerosis in IgA nephropathy

21. Ischemia-Induced Transplant Arteriosclerosis in the Rat

22. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

23. Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments

29. Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease.

30. Risk factors for reaching renal endpoints in the Assessment of Lescol in Renal Transplantation (ALERT) trial

31. Cardiovascular risk and renal transplantation : Post hoc analyses of the Assessment of Lescol in Renal Transplantation (ALERT) study

32. Long-term cardiac outcomes in renal transplant recipients receiving fluvastatin : The ALERT extension study

33. Effect of fluvastatin on renal end points in the Assessment of Lescol in Renal Transplant (ALERT) trial

36. Transplantation / Clinical studies

37. Inflammation-associated graft loss in renal transplant recipients

39. Effect of fluvastatin on cardiac outcomes in renal transplant recipients : A multicentre, randomised, placebo-controlled trial

Catalog

Books, media, physical & digital resources